Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The ExAblate Neuro device has been approved by the U.S. Food and Drug Administration to deliver focused ultrasound to destroy tissue in a tiny area of the brain that is thought to be involved in essential tremor.

FDA Approves Ultrasound Device to Treat Essential Tremor

Focused ultrasound device to treat essential tremor in patients who have not responded to medication
The first coronary stent to be gradually absorbed by the body has been approved by the U.S. Food and Drug Administration.

FDA Approves First Absorbable Coronary Stent

Device is absorbed by the body after about three years
The Xpert Carba-R Assay diagnostic

FDA Approves New Test to Help Detect Drug-Resistant Bacteria

Uses specimens taken directly from patients; specifically looks for resistance to carbapenems
An implant that helps the aging eye focus on small print and nearby objects has been approved by the U.S. Food and Drug Administration.

FDA Approves Eye Implant to Correct Presbyopia in Middle Age

Tiny lens reshapes cornea to improve focus on small print, close objects
The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus.

FDA Approves Epclusa for Chronic Hepatitis C

Combination drug treats six major strains of hepatitis C virus infection
Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response to UDCA

FDA Approves Ocaliva for Primary Biliary Cholangitis

For patients who have not responded to, or cannot tolerate, ursodeoxycholic acid
The U.S. Food and Drug Administration has approved the first-ever buprenorphine implant to treat opioid dependence

FDA Approves Probuphine Implant for Opioid Dependence

New form of treatment designed to last six months
The U.S. Food and Drug Administration has approved the first-ever buprenorphine implant to treat opioid dependence

FDA Approves Probuphine Implant for Opioid Dependence

New form of treatment designed to last six months
The Nutrition Facts panel on packaged foods in the United States is about to undergo long-awaited changes

FDA Redesigns Nutrition Facts Label

Added sugars, relevant portion sizes among the highlights of revision
The U.S. Food and Drug Administration has approved atezolizumab (Tecentriq)

FDA Approves Tecentriq to Treat Urothelial Carcinoma

FDA also approves a companion test to detect PD-L1 protein expression levels in patients